高级检索
当前位置: 首页 > 详情页

Chronic exercise improves renal AT1 and ETB receptor functions via modulating GRK4 expression in obese Zucker rats

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. [2]Guangzhou University of Chinese Medicine, Guangzhou, China. [3]Department of Nephrology, The Secondary Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China.
出处:
ISSN:

关键词: Exercise obesity hypertension angiotensin II type 1 receptor endothelin subtype B receptor GRK4

摘要:
Physical activity has profound benefits on health, especially in patients with cardiovascular and metabolic disease. Exercise training can reduce oxidative stress, improve renal function, and thus lower blood pressure. However, the effect of exercise training on angiotensin II type 1 receptors (AT1R) and endothelin subtype B receptors (ETBR)-mediated diuresis and natriuresis in obese Zucker rats is unclear.Lean and obese Zucker rats were exercised or placed on a nonmoving treadmill for 8 weeks. Blood pressure was measured by tail-cuff plethysmography, and functions of AT1R and ETBR in the kidney were measured by natriuresis, respectively.Our data showed that exercise training improved glucose and lipid metabolism, renal function and sodium excretion in obese Zucker rats, accompanied by decreased oxidative stress and GRK4 expression in obese Zucker rats. Moreover, exercise training reduced the Candesartan-induced an increase in diuresis and natriuresis and increased ETBR agonists (BQ3020)-mediated diuresis and natriuresis in obese Zucker rats, which were associated with decreased renal AT1R expression and ETBR phosphorylation levels.The results demonstrate that exercise training lowers blood pressure via improving renal AT1R and ETBR function through modulating GRK4 expression in Obese Zucker Rats and provides potentially effective targets for obesity-related hypertension.

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 4 区 医学
小类 | 4 区 外周血管病 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 外周血管病 4 区 药学
JCR分区:
出版当年[2022]版:
Q3 PERIPHERAL VASCULAR DISEASE Q3 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q3 PERIPHERAL VASCULAR DISEASE Q3 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. [2]Guangzhou University of Chinese Medicine, Guangzhou, China. [3]Department of Nephrology, The Secondary Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China.
通讯作者:
通讯机构: [1]The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. [2]Guangzhou University of Chinese Medicine, Guangzhou, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号